REG - Smith & Nephew Plc - Director/PDMR Shareholding

Smith & NephewAnnouncement

09/03/2022 18:15

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220309:nRSI2632Ea&default-theme=true

RNS Number : 2632E  Smith & Nephew Plc  09 March 2022

SMITH & NEPHEW PLC

 

9 March 2022

 

NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE REQUIREMENTS OF THE
EU MARKET ABUSE REGULATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL
RESPONSIBILITIES ("PDMR") AND PERSONS CLOSELY ASSOCIATED WITH THEM.

 

1.   VESTING OF SHARE AWARDS UNDER THE GLOBAL SHARE PLAN 2010 AND 2020

 

On 7 March 2022, the following awards of US$0.20 ordinary shares (the
"Shares") in Smith & Nephew plc (the "Company") vested under the Smith
& Nephew Global Share Plan 2010 and 2020.

 

i.     FINAL VESTING ON 7 MARCH 2022 OF 2019 EQUITY INCENTIVE PROGRAMME
AWARDS MADE UNDER THE GLOBAL SHARE PLAN 2010:

 

The awards were granted under the Global Share Plan 2010 on 7 March 2019. One
third of the Shares vested on 7 March 2020, a further third vested on 7 March
2021 and the final third vested on 7 March 2022. A number of Shares were sold
to cover taxation obligations arising on the vesting of the awards. The number
of Shares acquired includes the dividend equivalent Shares which participants
receive on vested Shares.

 

The following relates to individuals included in the below notification:

 

 Reason for the notification
 Initial notification /Amendment                              Initial notification
 Details of the issuer, emission allowance market participant, auction
 platform, auctioneer or auction monitor
 Name                                                         Smith & Nephew plc
 LEI                                                          213800ZTMDN8S67S1H61
 Details of the transaction(s): section to be repeated for (i) each type of
 instrument; (ii) each type of transaction; (iii) each date; and (iv) each
 place where transactions have been conducted
 Description of the financial instrument, type of instrument  Smith & Nephew plc ordinary shares of USD 0.20 each

 Identification code                                          ISIN: GB0009223206
 Nature of the transaction                                    Final vesting of Equity Incentive Programme awards granted on 7 March 2019
                                                              under the Smith & Nephew Global Share Plan 2010.
 Date of Transaction                                          2022 - 03 - 07
 Place of Transaction                                         London Stock Exchange (XLON)

 

 Name                                                                         Price (£)   Volume                                               Aggregated information  Total Ordinary Share Holding following the transaction *       Total Ordinary Share Holding as a % of the Company's ISC following the

                                                                                                                                                                transaction *
 (Position)                                                          Status
 Helen Barraclough                                                   PDMR     12.011211   2,417 (of which 1,140 were sold and 1,277 retained)  N/A Single Transaction  18,769.75378 ordinary shares                                   0.00212%

 (Group General Counsel)
 Bradley Cannon                                                      PDMR     12.011211   4,983 (of which 1,688 were sold and 3,295 retained)  N/A Single Transaction  81,825.17832 ordinary shares (including 2,718.50860 in ADS')   0.00924%

 (President, Orthopaedics, Sports Medicine & ENT and Americas)
 Phil Cowdy                                                          PDMR     12.011211   2,486 (of which 1,173 were sold and 1,313 retained)  N/A Single Transaction  48,446.96621 ordinary shares                                   0.00547%

 (Chief Business Development & Corporate Affairs Officer)
 Elga Lohler                                                         PDMR     12.011211   4,724 (of which 1,851 were sold and 2,873 retained)  N/A Single Transaction  109,689.00000 ordinary shares (including 3,015.00000 in ADS')  0.01239%

 (Chief HR Officer)
 Vasant Padmanabhan                                                  PDMR     12.011211   4,274 (of which 1,587 were sold and 2,687 retained)  N/A Single Transaction  67307.00000 ordinary shares                                    0.00760%

 (President Research & Development)
 Susan Swabey                                                        PDMR     12.011211   1,743 (of which 823 were sold and 920 retained)      N/A Single Transaction  50,970.39347 ordinary shares                                   0.00576%

 (Company Secretary)

 

* including those held by Persons Closely Associated with the Director/PDMR.
All figures in these columns are stated to 5 decimal places where applicable.

 

 

ii.   FINAL VESTING ON 7 MARCH 2022 OF SUPPLEMENTARY AWARDS GRANTED UNDER
THE SMITH & NEPHEW GLOBAL SHARE PLAN 2020 FOR THE 2019 PERFORMANCE SHARE
PROGRAMME AWARDS:

 

The awards were granted under the Global Share Plan 2020 on 8 March 2021. A
number of Shares were sold to cover taxation obligations arising on the
vesting of the awards.

 

The following relates to individuals included in the below notification:

 

 Reason for the notification
 Initial notification /Amendment                              Initial notification
 Details of the issuer, emission allowance market participant, auction
 platform, auctioneer or auction monitor
 Name                                                         Smith & Nephew plc
 LEI                                                          213800ZTMDN8S67S1H61
 Details of the transaction(s): section to be repeated for (i) each type of
 instrument; (ii) each type of transaction; (iii) each date; and (iv) each
 place where transactions have been conducted
 Description of the financial instrument, type of instrument  Smith & Nephew plc ordinary shares of USD 0.20 each

 Identification code                                          ISIN: GB0009223206
 Nature of the transaction                                    Final vesting on 7 March 2022 of Supplementary Awards granted under the Smith
                                                              & Nephew Global Share Plan 2020 for the 2019 Performance Share Programme
                                                              awards.
 Date of Transaction                                          2022 - 03 - 07
 Place of Transaction                                         London Stock Exchange (XLON)

 

 Name                                                                                 Price (£)   Volume                                               Aggregated information  Total Ordinary Share Holding following the transaction *       Total Ordinary Share Holding as a % of the Company's ISC following the

                                                                                                                                                                transaction *
 (Position)                                                                  Status
 Helen Barraclough                                                           PDMR     12.011211   3,013 (of which 1,422 were sold and 1,591 retained)  N/A Single Transaction  20,360.75378 ordinary shares                                   0.00230%

 (Group General Counsel)
 Bradley Cannon                                                              PDMR     12.011211   7,696 (of which 2,607 were sold and 5,089 retained)  N/A Single Transaction  86,914.17832 ordinary shares (including 2,718.50860 in ADS')   0.00982%

 (President, Orthopaedics, Sports Medicine & ENT and Americas)
 Phil Cowdy                                                                  PDMR     12.011211   5,641 (of which 2,661 were sold and 2,980 retained)  N/A Single Transaction  51,426.96621 ordinary shares                                   0.00581%

 (Chief Business Development & Corporate Affairs Officer)
 Simon Fraser                                                                PDMR     12.011211   6,791 (of which 2,021 were sold and 4,770 retained)  N/A Single Transaction  15,433.59428 ordinary shares                                   0.00174%

 (President, Advanced Wound Management & Global Commercial Operations)
 Elga Lohler                                                                 PDMR     12.011211   6,680 (of which 2,626 were sold and 4,054 retained)  N/A Single Transaction  113,743.00000 ordinary shares (including 3,015.00000 in ADS')  0.01285%

 (Chief HR Officer)
 Vasant Padmanabhan                                                          PDMR     12.011211   6,595 (of which 2,449 were sold and 4,146 retained)  N/A Single Transaction  71,453.00000 ordinary shares                                   0.00807%

 (President Research & Development)
 Susan Swabey                                                                PDMR     12.011211   2,446 (of which 1,154 were sold and 1,292 retained)  N/A Single Transaction  52,262.39347 ordinary shares                                   0.00590%

 (Company Secretary)

 

* including those held by Persons Closely Associated with the Director/PDMR.
All figures in these columns are stated to 5 decimal places where applicable.

 

 

2.   PHIL COWDY - SALE OF ORDINARY SHARES

 

 Reason for the notification
 Initial notification /Amendment                              Initial notification
 Details of the issuer, emission allowance market participant, auction
 platform, auctioneer or auction monitor
 Name                                                         Smith & Nephew plc
 LEI                                                          213800ZTMDN8S67S1H61
 Details of the transaction(s): section to be repeated for (i) each type of
 instrument; (ii) each type of transaction; (iii) each date; and (iv) each
 place where transactions have been conducted
 Description of the financial instrument, type of instrument  Smith & Nephew plc ordinary shares of USD 0.20 each
 Identification code                                          ISIN: GB0009223206
 Nature of the transaction                                    Sale of ordinary shares.
 Date of Transaction                                          2022 - 03 - 08
 Place of Transaction                                         London Stock Exchange (XLON)

 

 Name (Position)                                                Director / PDMR  Price (£)   Volume  Aggregated information  Total Ordinary Share Holding following the transaction *  Total Ordinary Share Holding as a % of the Company's ISC following the
                                                                                                                                                                                       transaction *
 Phil Cowdy                                                     PDMR             11.793781   4,293   N/A Single Transaction  47,133.96621 ordinary shares                              0.00532%

 (Chief Business Development & Corporate Affairs Officer)

 

* including those held by Persons Closely Associated with the Director/PDMR.
All figures in these columns are stated to 5 decimal places where applicable.

 

 

Sarah Carne

Deputy Company Secretary

Smith & Nephew plc

 

Tel:  +44 (0)1923 477100

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHFLFEDVAIAIIF